Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05028712 · ClinicalTrials.gov registry record · NA

Development of a Multi-sensory Rehabilitation Program for People With Ultra Low Vision

A NA study of Quality of Life and Visual Impairment, sponsored by State University of New York College of Optometry.

Recruiting
Registry status
NA
Development phase
36
Enrollment target
1
Study location

NCT05028712: Recruiting NA study of Quality of Life and Visual Impairment, sponsored by State University of New York College of Optometry.

NCT05028712 is a NA study of Quality of Life and Visual Impairment that is actively recruiting participants, run by State University of New York College of Optometry. The registered enrollment target is 36 participants, below the 452-participant average among 107 other Quality of Life trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05028712, a NA study of Quality of Life and Visual Impairment, is actively recruiting participants, sponsored by State University of New York College of Optometry.

RECRUITING
Registry status
NA
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

This research is aimed to address one of the big gaps in the current vision rehabilitation protocols for people with profound visual impairment by evaluating a multisensory approach. There are a growing number of clinical trials that recruit people with end-stage eye diseases and the rehabilitation plan following various treatments is not clear. It is important to address this in order to maximize the efficacy of such treatments and to improve the quality of life in people with profound visual impairment.

Primary Outcome

Change in visual ability as measured by the Ultra Low Vision Visual Function Questionnaire. The scale measures both visual ability (Person Measure) and difficulty (Item Measure) in people with ultra low vision. 150 items on a likert scale ranging from 1 impossible, to 4 not difficult. Using a Rasch-Andrich rating model, Person Measures range from -6 to +2.8 logits, Item Measures range from -3.3 to +3.0 logits. Higher scores indicating better outcome.

Interventions

  • BEHAVIORAL Visual Information Training
  • BEHAVIORAL Multimodal training

Study Locations (1)

New York

  • SUNY College of Optometry - New York

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2024-03-08
Est. Completion 2026-07
Phase NA

What NCT05028712 shows while recruiting

NCT05028712 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 452-participant average among 107 other Quality of Life trials with a reported enrollment target (92% lower).

The record links to 4 conditions, with Quality of Life appearing as the primary indexed condition, and to 2 interventions - of which Visual Information Training is the first listed.

NCT05028712 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05028712 about?

NCT05028712 is a clinical study titled "Development of a Multi-sensory Rehabilitation Program for People With Ultra Low Vision". This research is aimed to address one of the big gaps in the current vision rehabilitation protocols for people with profound visual impairment by evaluating a multisensory approach. There are a growing number of clinical trials that recruit people with end-stage eye diseases and the rehabilitation ...

What is the current status of trial NCT05028712?

This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2024-03-08. Estimated completion is 2026-07.

What conditions does trial NCT05028712 study?

This clinical trial studies the following conditions: Quality of Life, Visual Impairment, Low Vision Blindness, Functional Visual Loss.

What interventions are being tested in trial NCT05028712?

The interventions under investigation include: Visual Information Training (BEHAVIORAL), Multimodal training (BEHAVIORAL).

Who is sponsoring clinical trial NCT05028712?

This trial is sponsored by State University of New York College of Optometry, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05028712 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Quality of Life

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05028712's enrollment target sits among peer trials

36 86th of 107 higher than 20 of 107 other Quality of Life trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Quality of Life trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05028712, the US trial registry maintained by the National Library of Medicine. NCT05028712 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.